Wall Street brokers expect Universal Health Services, Inc. (NYSE:UHS – Get a rating) to post $3.32 billion in sales for the current fiscal quarter, according to Zacks. Three analysts provided earnings estimates for Universal Health Services. The highest sales estimate is $3.36 billion and the lowest is $3.30 billion. Universal Health Services posted sales of $3.20 billion in the same quarter last year, which would indicate a positive growth rate of 3.8% year over year. The company is expected to release its next results on Monday, January 1.
On average, analysts expect Universal Health Services to report annual revenue of $13.48 billion in the current fiscal year, with estimates ranging from $13.44 billion to $13.59 billions of dollars. For the next fiscal year, analysts expect the company to post sales of $14.12 billion, with estimates ranging from $13.91 billion to $14.23 billion. Zacks Investment Research sales averages are an average based on a survey of research analysts who provide coverage for universal health services.
Universal Health Services (NYSE: UHS – Get a rating) last released its quarterly results on Monday, April 25. The healthcare service provider reported earnings per share (EPS) of $2.15 for the quarter, missing analyst consensus estimates of $2.47 per ($0.32). Universal Health Services posted a net margin of 7.25% and a return on equity of 15.06%. The company posted revenue of $3.29 billion in the quarter, versus analyst estimates of $3.24 billion. During the same period a year earlier, the company posted EPS of $2.44. Universal Health Services revenue increased 9.3% compared to the same quarter last year.
Several stock analysts have weighed in on UHS shares. The Royal Bank of Canada lowered its target price on universal health services from $149.00 to $130.00 in a research report Wednesday, April 27. Citigroup raised its price target on Universal Health Services from $162.00 to $167.00 in a Tuesday, March 1 research report. Mizuho lowered its price target on Universal Health Services from $164.00 to $153.00 in a Tuesday, May 3 report. UBS Group raised its price target on Universal Health Services from $124.00 to $134.00 and gave the company a “sell” rating in a Monday, March 7 report. Finally, Seaport Res Ptn downgraded Universal Health Services from a “buy” rating to a “neutral” rating in a Sunday, February 27 research note. Four analysts rated the stock with a sell rating, five gave the company a hold rating and five issued a buy rating. Based on MarketBeat data, Universal Health Services currently has a consensus rating of “Hold” and an average target price of $149.69.
NYSE UHS opened at $121.41 on Wednesday. The company has a market capitalization of $9.08 billion, a PE ratio of 10.64, a P/E/G ratio of 2.51 and a beta of 1.10. Universal Health Services has a 52 week minimum of $116.23 and a 52 week maximum of $165.00. The company’s fifty-day simple moving average is $137.04 and its 200-day simple moving average is $134.06. The company has a quick ratio of 0.98, a current ratio of 1.07 and a debt ratio of 0.71.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 15. Shareholders of record on Wednesday, June 1 will receive a dividend of $0.20. The ex-dividend date is Tuesday, May 31. This represents a dividend of $0.80 on an annualized basis and a dividend yield of 0.66%. Universal Health Services’ dividend payout ratio (DPR) is 7.01%.
Universal Health Services said its board of directors approved a stock repurchase program on Thursday, Feb. 24 that allows the company to repurchase $1.40 billion in outstanding stock. This repurchase authorization allows the health service provider to repurchase up to 12.1% of its shares through open market purchases. Share repurchase programs usually indicate that the company’s board of directors believe its shares are undervalued.
In other Universal Health Services news, Director Lawrence S. Gibbs sold 1,307 shares of Universal Health Services in a trade on Friday, March 11. The stock was sold at an average price of $153.00, for a total transaction of $199,971.00. The sale was disclosed in an SEC filing, available at this hyperlink. Also, director Eileen C. Mcdonnell sold 296 shares of the company in a transaction on Monday, February 28. The stock was sold at an average price of $141.17, for a total value of $41,786.32. Disclosure of this sale can be found here. Insiders of the company own 15.40% of the shares of the company.
Several large investors have recently changed their positions in UHS. Vanguard Group Inc. increased its position in Universal Health Services shares by 1.9% during the first quarter. Vanguard Group Inc. now owns 7,856,010 shares of the healthcare provider worth $1,138,729,000 after buying an additional 146,820 shares in the last quarter. BlackRock Inc. increased its position in Universal Health Services by 2.3% in the 1st quarter. BlackRock Inc. now owns 5,026,512 shares of the healthcare provider valued at $728,594,000 after buying an additional 113,259 shares in the last quarter. First Eagle Investment Management LLC increased its position in Universal Health Services by 1.4% in the 1st quarter. First Eagle Investment Management LLC now owns 4,155,489 shares of the healthcare provider valued at $602,338,000 after buying an additional 56,358 shares in the last quarter. Invesco Ltd. increased its stake in shares of Universal Health Services by 3.9% in the 1st quarter. Invesco Ltd. now owns 3,957,991 shares of the healthcare provider valued at $573,711,000 after purchasing an additional 146,774 shares during the period. Finally, American Century Companies Inc. increased its stake in Universal Health Services shares by 15.6% in the 4th quarter. American Century Companies Inc. now owns 2,269,854 shares of the healthcare provider valued at $294,310,000 after purchasing an additional 307,066 shares during the period. 89.41% of the shares are held by institutional investors.
About Universal Health Services (Get a rating)
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals and ambulatory and behavioral health care facilities. The Company operates through the Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialized surgery, internal medicine, obstetrics, emergency care, radiology, oncology, diagnostic and coronary care, pediatrics, pharmacy and/or behavioral health.
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in universal health services right now?
Before you consider universal health services, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and Universal Health Services was not on the list.
While Universal Health Services currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here